Influenza and pneumococcal vaccination in hospitalized adults with pandemic (H1N1) 2009: Immunization practices and impact on clinical presentation and outcomes
Journal Title: Journal of Vaccines & Immunization - Year 2013, Vol 1, Issue 3
Abstract
The purpose of this study was to determine vaccination rates against influenza and pneumococcus in a large cohort of adults hospitalized with confirmed influenza A(H1N1) pdm09 infection, and to identify differences in clinical features, frequency of bacterial coinfection, and outcomes between vaccinated and non-vaccinated patients. A prospective cohort study conducted at 14 teaching hospitals in Spain. Adult patients (n=699) hospitalized with confirmed influenza A(H1N1)pdm09 infection during the pandemic and the first post pandemic influenza periods were included. Vaccination status against influenza and pneumococcus was established in 547 and 587 individuals, respectively. The vaccination rates were low: 14% for seasonal influenza and 5.4% for pneumococcus. Despite conducting whole population and subgroup multivariate analyses, we observed no beneficial effects on outcomes (intensive care unit admission and mortality) for both vaccines. However, patients who had been vaccinated, whether against influenza or pneumococcus, did tend to develop fewer bacterial coinfections, particularly that due to S. pneumoniae.
Authors and Affiliations
Payeras A, Riera M, Viasus D, Gálvez-Acebal J, Oteo JA, Gracia-Ahufinger I, Caro-Bragado S, Cordero E, Martínez-Montauti J, Fariñas MC, Carratalà J
Keywords
Related Articles
- EP ID EP567026
- DOI 10.14312/2053-1273.2013-4
- Views 36
- Downloads 0
Impact of strategies and activities for reducing morbidity and mortality of vaccine-preventable diseases in Oman: A status report
Immunization is the only child survival strategy which alone averts two to three million deaths each year. This has been possible because of high coverages achieved by many countries in the world. Still nearly 1.5 millio...
Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuated parental strain
Live attenuated mumps vaccines have been developed by passaging the field isolates in cells that differ from the natural host. To study mumps viral (MuV) attenuation at the genomic level, we compared a live attenuated mu...
An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine
We examined the validity of the indirect cohort method as a rapid assessment tool to estimate pneumococcal polysaccharide vaccine effectiveness (VE). Using evidence from published clinical trials, we reviewed the primary...
Developing a vaccine for human rhinoviruses
Rhinoviruses (RV’s) are common human pathogens of the respiratory tract being the most frequent cause of mild diseases of the upper respiratory tract (common cold) but more importantly they are a major initiator of acute...
Suboptimal vaccination rates in rural Ghana despite positive caregiver attitudes towards vaccination
Background: Vaccines save more than 3 million lives and prevent 750,000 disabilities each year. Optimum immunization coverage will help in the fight against infectious diseases. This study was carried out to characterize...